CEBPA and acute myeloid leukemia: Our analysis comparing data-driven identification of AML molecular subtypes from TCGA, Hemap and BeatAML datasets revealed a distinct clustering of CEBPA, NPM1, RUNX1 and TP53 mutation positive samples.